STAT+: Patient with liver damage in Intellia trial dies

This is the online version of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. Morning! Lots in biotech today…. New priority review vouchers from the FDA, Mark Cuban rolls out a biosimilar deal, and a patient death is reported in Intellia’s CRISPR trial. Trump’s priority review vouchers […]

Does Microdosing GLP-1s Work? Expert Weighs In

(MedPage Today) — Welcome to Culture Clinic, MedPage Today’s collaboration with Northwell Health to offer a healthcare professional’s take on the latest viral medical topics. More companies are promoting microdosing GLP-1 receptor agonists even…

Peptides on Tap: Automated Flow Synthesis with Standard HPLC

Peptide synthesis is central to biomedical research, yet automated flow synthesis typically requires custom-built instrumentation, limiting accessibility beyond specialized laboratories. Here we demonstrate that a standard analytical HPLC can be repurposed for fully automated flow-based peptide synthesis. By packing a short guard column with resin and programming reagent injections through the autosampler, we achieved efficient […]

How much do popular obesity drugs cost?

Popular weight loss drugs like Wegovy and Zepbound will soon cost Americans less under a new deal announced by President Donald Trump on Thursday. Agreements with drugmakers Novo Nordisk and Eli Lilly will slash the prices of so-called GLP-1 drugs, which could eventually cost as little as $149 per month. The average price of the […]